Form 4 for ABT Abbott Laboratories
Accepted 2022-07-01 00:00:00 ET · period of report 2022-07-01 · accession 0001415889-22-007180 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-01 | 2022-07-01 | ABT | Calamari Christopher J. | SVP | F - Tax | $108.65 | -569 | 25.1K | -2% | -$61.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2022-07-01 | F | D | 569 | $108.65 | 25,089 | D | — | — |